Article
31 Jul 2024
U.S. Senate Unanimously Passes Bill Limiting Number Of Patents Asserted Against Biosimilar Applicants
AUTHORS CONTENT
Article
09 Jul 2024
Federal Circuit Revives Induced Infringement Claims Despite "Skinny Label" Carve-Out
Article
12 Oct 2022
USPTO Seeks Public Input On Improving Patent "Robustness And Reliability"
Article
25 Jan 2022
Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug
Article
29 Sep 2021
Patent Linkage And Article 76 Proceedings In China: A Litigator's Perspective
Article
24 Sep 2021
Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement
Article
25 Apr 2019
Polymorph Patent Not Invalid As Obvious
Article
11 Jul 2018
High Court To Hear Helsinn v. Teva, Resolve AIA Secret Sales Question
Article
26 Jun 2017
Supreme Court: Biosimilar Applicants May Provide Commercial Marketing Notice Before FDA Approval
Article
14 Apr 2016
美国安进公司新起诉以寻求关于美国生物性产品价格竞争与创新法案